End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 EUR | -0.91% | -2.68% | -3.54% |
2018 | MAX 21 AG announced that it has received €0.722004 million in funding | CI |
2018 | MAX 21 AG announced that it expects to receive €0.722004 million in funding | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.54% | 8.1M | - | ||
+10.38% | 321B | B- | ||
+26.67% | 220B | B+ | ||
+3.34% | 150B | B | ||
+12.86% | 57.95B | D+ | ||
+14.48% | 32.83B | C+ | ||
+2.97% | 30.47B | B+ | ||
+29.23% | 21.13B | B- | ||
+97.26% | 20.94B | D+ | ||
+1.96% | 14.97B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MA10 Stock
- MA1 Stock
- Ratings MAX 21 AG